EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

RNA ‐Based Therapies for Inherited Metabolic Disorders

Reddy Sreekanth Vootukuri, Sonam Gurung, Roopkatha Ghosh, Philippa B Mills iD, Julien Baruteau, Haiyan Zhou

Journal of Inherited Metabolic Disease · 2026-03 · 49 (2)

DOI: 10.1002/jimd.70150 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Inherited Metabolic Disease, online erschienen am 01.02.2026. Verfasst von Reddy Sreekanth Vootukuri und 5 weiteren Autor:innen. Beteiligte Einrichtung: Genetics and Genomic Medicine, University College London Great Ormond Street Institute of Child Health, London, UK. Hauptthemen laut MEDLINE: RNA, Small Interfering, Genetic Therapy, Metabolism, Inborn Errors, Metabolic Diseases. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 222 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Great Ormond Street Hospital Charity, Citrin Foundation, Moderna.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inherited metabolic disorders (IMDs) are a diverse and complex group of genetic conditions resulting from deficiencies in enzymes, transporters, or cofactors. These deficiencies lead to metabolic dysfunction and severe clinical consequences. Despite significant progress in understanding their molecular basis, treatment options remain limited for many IMDs. RNA‐based therapies including antisense oligonucleotides (AONs), small interfering RNAs (siRNAs), and messenger RNA (mRNA) therapeutics have emerged as promising treatment strategies for modulating gene expression, silencing pathogenic transcripts, and restoring deficient proteins, offering new avenues for disease intervention. In this review, we summarise the chemistry and mechanisms of action of different RNA therapy modalities including splice‐modulating and gene silencing AONs, siRNAs, and mRNA therapies. The delivery of these RNA‐based therapies remains a significant challenge. Here, we outline the development of various delivery methods, including lipid nanoparticle (LNP) packaging, ligand conjugation, and tissue‐specific delivery systems as well as their clinical applications in treating IMDs. We also summarise the clinical application of RNA therapies in rare diseases, an area that has grown rapidly in the last few years, as exemplified by the success of some n‐of‐1 therapies for IMDs, which have redefined personalised medicine by enabling rapid, patient‐specific drug development. As RNA‐based therapeutics continue to evolve, their clinical applications in IMDs will require continued innovation in novel chemistries, advanced delivery technologies, and streamlined regulatory frameworks to unlock their full potential.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA, Small InterferingGenetic TherapyMetabolism, Inborn ErrorsMetabolic DiseasesHumansOligonucleotides, AntisenseAnimalsRNA, MessengerNanoparticles

Stichwörter der Autor:innen

AONRNA therapygene silencinginborn errors of metabolismmRNAn‐of‐1siRNA

Substanzen

RNA, Small InterferingOligonucleotides, AntisenseRNA, Messenger

Autor:innen und Institutionen

  • Genetics and Genomic Medicine, University College London Great Ormond Street Institute of Child Health, London, UK.
  • NIHR Great Ormond Street Hospital Biomedical Research Centre, London, UK.
  • Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.

ORCID-Profile: Philippa B Mills

Förderung

  • Great Ormond Street Hospital Charity
  • Citrin Foundation
  • Moderna
  • Medical Research Council
  • Engineering and Physical Sciences Research Council
  • Royal Society
  • SMA Europe
  • Rosetrees Trust

Zitieren

APA

Vootukuri, R. S., Gurung, S., Ghosh, R., Mills, P. B., Baruteau, J., & Zhou, H. (2026). RNA ‐Based Therapies for Inherited Metabolic Disorders. Journal of Inherited Metabolic Disease, 49(2). https://doi.org/10.1002/jimd.70150

Vancouver

Vootukuri RS, Gurung S, Ghosh R, Mills PB, Baruteau J, Zhou H. RNA ‐Based Therapies for Inherited Metabolic Disorders. Journal of Inherited Metabolic Disease. 2026;49(2). doi:10.1002/jimd.70150

BibTeX
@article{Vootukuri2026,
  author = {Vootukuri, Reddy Sreekanth and Gurung, Sonam and Ghosh, Roopkatha and Mills, Philippa B and Baruteau, Julien and Zhou, Haiyan},
  title = {RNA ‐Based Therapies for Inherited Metabolic Disorders},
  journal = {Journal of Inherited Metabolic Disease},
  year = {2026},
  volume = {49},
  number = {2},
  doi = {10.1002/jimd.70150}
}
Kostenlos starten →